Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2885 SEK | -3.35% | -10.40% | -97.12% |
05-22 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
XBRANE BIOPHARMA AB | Other Biotechnology & Medical Research | -3.35% | -10.40% | -97.12% | -99.64% | -99.25% | 41.88M |
- Stock Market
- Equities
- XBRANE Stock
- Charts Xbrane Biopharma AB
- Relative Strength Chart